The groundbreaking therapy of this peptide represents a major advance in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide803376.suomiblog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-57881289